San Diego, CA-based start-up Dionysus Digital Health hopes to become the first company to receive US regulatory clearance for a blood test that can accurately predict a woman’s risk of postpartum depression.
Currently, there are no biological tests to identify a woman’s risk for postpartum depression, a condition that affects about 10%-15% of 3 million women giving birth each year in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?